CAS 1008763-54-9

3-(2-Aminoethyl)-1,3-dihydro-5-methoxy-1-[[(1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl]carbonyl]-2H-benzimidazol-2-one hydrochloride

CAS : 1008763-54-9

Formule : C₂₁H₃₂ClN₃O₃

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 409.9501

Ref: IN-DA008TFC

D-3263 hydrochloride

CAS : 1008763-54-9

D-3263 hydrochloride

Degré de pureté : ≥98%

Masse moléculaire : 409.95g/mol

Ref: 54-BUP16291

D-3263 hydrochloride

CAS : 1008763-54-9

D-3263 hydrochloride is a novel drug that has been shown to be effective against chronic kidney disease. This drug is an orally active small molecule that was identified by the use of a multivariable approach in the chemical biology field. D-3263 hydrochloride has been shown to bind to specific targets (e.g., markers) and inhibit cancer cell proliferation and growth, as well as induce cancer cell death. It also inhibits angiogenesis, which is the formation of new blood vessels from pre-existing ones, and can be used for cancer therapy. The mechanism of action of this drug is unknown but may involve redox signaling pathways and gaseous molecules.

Formule : C₂₁H₃₂ClN₃O₃

Degré de pureté : Min. 95%

Masse moléculaire : 409.95 g/mol

Ref: 3D-IQB76354

D-3263 hydrochloride

CAS : 1008763-54-9

D-3263 hydrochloride (D3263 HCl salt) is enteric-coated, orally bioavailable transient receptor potential melatonin member 8 (TRPM8) agonist.

Formule : C₂₁H₃₂ClN₃O₃

Degré de pureté : 99.93%

Couleur et forme : Solid

Masse moléculaire : 409.95

Ref: TM-T10929L